However, detailed results from these trials have not been published in peer-reviewed journals, limiting comprehensive assessment of clinical efficacy
For patients who want to slow or partially reverse age-related cognitive changes, Synapse offers an approach that no traditional nootropic can replicate
Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously
Peptides like BPC-157 are being studied for their role in tissue repair, reducing inflammation, and supporting immune function
His pioneering work isolated thymosin beta-4 from bovine thymus tissue and characterized its immunological and regenerative properties
It increases natural GH and IGF-1 secretion, especially when paired with a GH secretagogue like Ipamorelin